Babineaux-Fontenot Claire bought ABT
April 24, 2026 · Form 4 insider transaction
Babineaux-Fontenot Claire bought 2,286 shares of Abbott Laboratories at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,286
Price
$0.00
Total value
N/A
InsiderBabineaux-Fontenot Claire
RoleDirector
CompanyAbbott Laboratories (ABT)
SecurityCommon shares without par value
Transaction codeA: Grant or award
Transaction dateApril 24, 2026
Filing dateApril 28, 2026
Shares owned after7,603
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).